ABEONA THERAPEUTICS INC. Deferred Revenue, Current
ABEONA THERAPEUTICS INC. (ABEO) had Deferred Revenue, Current of $296.00 thousand as of 2021-12-31, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2022-11-14
- 2021-12-31: Deferred Revenue, Current $296.00K.
- 2021-09-30: Deferred Revenue, Current $296.00K.
- 2021-06-30: Deferred Revenue, Current $296.00K.
- 2021-03-31: Deferred Revenue, Current $296.00K.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2021-12-31 | $296.00K 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $296.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $296.00K 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $296.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $296.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $296.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $296.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $296.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $296.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $296.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $296.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $296.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $296.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $800.00K 10-Q · filed 2018-11-09 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.60M 10-Q · filed 2018-11-09 | $544.00K 10-Q · filed 2018-05-10 |
| 2018-01-02 | $2.60M 10-K · filed 2020-03-16 | $2.61M 10-Q · filed 2018-05-10 |
| 2018-01-01 | $0.00 10-K · filed 2019-03-18 | |
| 2017-12-31 | $2.60M 10-K · filed 2020-03-16 | $3.21M 10-K · filed 2018-03-16 |
| 2017-09-30 | $602.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $602.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $602.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $602.00K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $602.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $602.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $602.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $602.00K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $602.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $602.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $602.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $602.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $602.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $602.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $602.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $578.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $577.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $577.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $247.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $247.00K 10-K · filed 2014-03-26 | |
| 2012-09-30 | $248.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $248.00K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $239.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $285.00K 10-K · filed 2013-03-20 | |
| 2011-09-30 | $285.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $347.00K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $347.00K 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |